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Nanoparticles have the potential to exhibit risks to human beings and to the environment; due to the wide applications of
nanoproducts, extensive risk management must not be neglected. Therefore, we have constructed a cell-based, iterative screening
system to examine a variety of nanoproducts concerning their toxicity during development. The sensitivity and application of
various cell-based methods were discussed and proven by applying the screening to two different nanoparticles: zinc oxide and
titanium dioxide nanoparticles. They were used as benchmarks to set up our methods and to examine their effects on mammalian
cell lines. Different biological processes such as cell viability, gene expression of interleukin-8 and heat shock protein 70, as well as
morphology changes were investigated. Within our screening system, both nanoparticle suspensions and coatings can be tested.
Electric cell impedancemeasurements revealed to be a goodmethod for onlinemonitoring of cellular behavior.The implementation
of three-dimensional cell culture is essential to better mimic in vivo conditions. In conclusion, our screening system is highly
efficient, cost minimizing, and reduces the need for animal studies.
1. Introduction
Nanoparticles have been used in many applications over
the last decades such as cosmetics, medicine, and paints. In
2012 more than 100 products containing nanoparticles were
available [1]. However, the constantly increasing amount of
industrial as well as consumer nanoproducts requires reliable
and extensive risk management, as interactions with human
beings and the environment are becoming more frequent.
Various public exposure paths are possible [2], but up to now
no standardized guideline for nanoparticle and nanomateri-
als testing exists [1, 3]. Currently for nanoparticle testing in
vitro, only the commonly used assays validated for drug test-
ing are available. However, nanoparticles differ significantly
from normal chemicals [2] and can interfere with the assays
[1–4].
In particular, oxidized nanoparticles are able to reduce
assay dyes, causing an underestimation of the cytotoxicity by
overestimating cell viability [5]. Furthermore, a key challenge
of in vitro nanoparticle safety testing is determining the
stability of nanoparticles in biological media. For a plurality
of nanoparticles, stable nanoparticle suspensions exhibit an
acidic pH value and/or contain different stabilizing agents.
Thus, adding nanoparticles for in vitro cytotoxicity assays
directly to the physiological aqueous culture media often
results in nanoparticle aggregation and agglomeration [2, 6,
7].
While these limitations in nanoparticle cytotoxicity mea-
surements are known, as long as alternative assays have
not been developed, careful examinations of the results
are needed. Furthermore, when choosing a method for
nanoparticle testing it must be excluded that false-positive
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results can be misinterpreted. Nevertheless, for nanoparticle
cytotoxicity studies in vitro, cell-exposure studies can yield
the first evidence of their potential risk. These tests offer the
advantages to be simple and to clarify the basic interaction
[1]. Additionally, these methods are rapid, cheaper, and more
reproducible than in vivo systems [1]. Thus, in vitro studies
are often used before animal studies are applied. However,
there are concerns whether the results of these studies can
really predict in vivo cell behavior. A comparative study of
the effects of TiO
2
nanoparticles demonstrated a good corre-
lation between acute toxicity measurements of in vitro and in
vivo tests based on the steepest slopes of dose response curves
[8]. Moreover, Kim et al. could identify higher cytotoxicity
of nanosized SiO
2
as compared with microsized particles in
vitro as well as in vivo [9].
To improve the prediction of in vivo effects a set of in
vitro assays investigating different mechanism is needed [9].
As in vitro assays cannot mimic real tissue conditions also
more complex in vitro models like three-dimensional (3D)
cell culture models could bridge the gap between classical
two-dimensional (2D) in vitromodels and in vivo studies.
The development of consumer nanomaterials implies
long optimization procedures resulting in the formation of
plenty of precursors and intermediates. All these materials
may pose risks to human beings and the environment.
All these materials must be tested for toxicity, especially
with regards to occupational safety provision and consumer
protection. However, the number of in vitro cytotoxicity
assays currently available is huge; consequently, all of these
assays cannot be applied for all precursors, intermediates, and
products.Moreover, animal studies are ethically controversial
and therefore limited. Thus, a broad and complex study can
often not be performed because the bottlenecks are in vitro
cell-based toxicity tests and in vivo animal studies which are
very time consuming and costly.
Therefore, the aim of our study was the development
of an in vitro hierarchical nanoparticle screening system to
examine any kind of nanoparticles concerning their toxicity.
First, the structure of the screening system is presented
in general. Next is a separate section of the prescreening,
fine-screening, and complex-screening where the sensitivity
and difficulties of the cytotoxicity assays are discussed. The
application of the methods in each screening level was
proven exemplary with two different kinds of nanoparticles.
This screening system includes different cytotoxic assays and
complex cell culture systems such as a three-dimensional
cell culture or dynamic cultivation to increase the relevance
of in vitro assays. As nanoparticle suspension testing has
limitations regarding the cell culture, we studied whether
similar results can be obtained with nanoparticle suspensions
and with coating experiments, respectively. According to the
possible nanoparticle incorporation into the human organ-
ism, we used human lung carcinoma A549 cells (respiratory
tract) and murine fibroblasts NIH-3T3 cells (skin). As a
benchmark-system for the development of the screening
system we investigated the effects of zinc oxide nanoparticles
(ZnO-NP) and titanium dioxide nanoparticles (TiO
2
-NP)
on mammalian cell lines. These two nanoparticle types have
been used in different applications and their influence on 2D
monolayer cultures has been analyzed previously. For ZnO-
NP cytotoxic effects have been published [3, 10–12] while the
cytotoxicity of TiO
2
-NP is still a point of discussion. Some
studies have reported nontoxic effects for TiO
2
-NP [13, 14]
whereas other studies suggested cytotoxic effects of TiO
2
-NP
[14–16]. In the present study both types of nanoparticles were
screened with the developed screening system.
2. Materials and Methods
2.1. Nanoparticles. In this study ZnO-NP (with 0.1% Ru)
were used, which were synthesized and characterized by Bloh
et al. (2012, 2014) [17, 18]. The ZnO-NP have a Brunauer–
Emmett–Teller (BET) surface of 6.54m2/g and a particle
size of 50 ± 10 nm (X-ray) [17]. ZnO-NP exhibited an
average hydrodynamic diameter (dynamic light scattering)
of 41 ± 5 nm in water, 190 ± 3 nm in Dulbecco’s Modified
Eagle Medium (DMEM), and 106 ± 11 nm in the standard
culturemedium (mean± standard derivation) [19].TheTiO
2
-
NP (Hombikat XXS 700) were obtained from Sachtleben,
Duisburg, Germany, exhibiting a primary particle size of
7 nm (REM) in the anatase form according to the data sheet.
The hydrodynamic diameter of TiO
2
-NP has been reported
previously by Sambale et al. [19]. In water TiO
2
-NP have a
diameter of 79 ± 25 nm, in DMEM 142 ± 29 nm, and in the
culture medium 118 ± 28 nm [19].
2.2. Cell Culture. A549 human lung carcinoma cells (DSMZ
number: ACC 107) and NIH-3T3 mouse fibroblasts cells
(DMSZ number: ACC 59) were purchased from the German
Collection of Microorganisms and Cell Cultures (DSMZ).
Both cell lines used here were cultivated in Dulbecco’s
Modified Eagle’s Medium (DMEM) (D7777 Sigma-Aldrich,
Steinheim,Germany) supplementedwith 10% fetal calf serum
(FCS) and 100 𝜇g/mL antibiotics (penicillin/streptomycin) in
a humidified environment at 37∘C/5% CO
2
. Every 3 or 4 days
cells were subcultivated when the cultures reached 70–80%
confluence.The passage number of all used cells was less than
20.
2.3. 3D Cell Culture. For 3D cell cultures, two different 3D
cell culture models were performed. 20,000 cells were seeded
on each side of a round scaffold of 1mm thickness and
7mm diameter via pipetting (Matriderm, Medskin Solution
Dr. Suwelack AG, Germany). The scaffolds were placed in a
24-well plate and were incubated at 37∘C/5% CO
2
for 72 h
to allow the cells to adhere and to build a 3D structure.
Afterwards, the cells were treated in triplicate with different
concentrations of ZnO-NP or TiO
2
-NP in the cell culture
medium for 24 h. As a second model, cell encapsulation
in a semisynthetic PEG-fibrinogen-based hydrogel (Faculty
of Biomedical Engineering, Technion, Haifa, Israel) was
investigated. Here, 1mL hydrogel (fibrinogen concentration
of 8mg/mL) contains 1 × 106 cells and 10 𝜇L photoinitiator
(10% (w/v) in 70% ethanol). For generating defined hydrogel
constructs, 50 𝜇L of the hydrogel-cell-mixture was added to
a 6mm silicon gasket (Grace Bio-Labs silicone gasket for
ProPlate microarray system, Sigma-Aldrich, USA). Covalent
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cross-linking of the hydrogel was performed with UV light
(6W, 365 nm, VL-6L, Vilber Lourmat, France) for 2min.
Then, each hydrogel construct was placed in a 24-well
plate containing 500𝜇L cell culture medium. Additionally,
hydrogel constructs without cells were used as controls. To
allow the cells to adhere in the hydrogel, to proliferate, and to
be connected to 3D network the cells were incubated for 48 h
before nanoparticle exposure for 24 h was performed.
2.4. Nanoparticle Testing. According to their doubling time
a defined number of cells were seeded for each cell line.
The A549 cells exhibit a doubling time of 40 hours, whereas
NIH-3T3 cells exhibit a doubling time of 20 hours. For 2D
cell culture experiments 8,000 A549 cells/well and 6,000
NIH-3T3 cells/well were seeded in 96-well plates (Sarstedt
AG) and different exposure methods of ZnO-NP and TiO
2
-
NP were investigated. For nanoparticle testing in suspension
an aqueous nanoparticle suspension was diluted with cell
culture media. The cells were cultured for 24 h in 100 𝜇L
standard culture medium before nanoparticle treatment and
were exposed to different concentrations of nanoparticles
for 24 h (triplicate). For coating experiments the cells were
seeded directly on nanoparticle coatings (triplicate) and cell
viability was determined after 48 h. In order to analyze
whether nanoparticles have entered the solution from the
nanoparticle coatings, extracts were prepared according to
the ISO standard 10993-12:2012 (Biological Evaluation of
Medical Devices–Part 12: Sample Preparation and Reference
Materials) [20].Therefore, 3 cm2/mL cell culturemediumwas
added to the nanoparticles coatings (different concentrations
in triplicate) and were placed in an incubator at 37∘C and 5%
CO
2
for 24 h.Then standard culture medium was replaced to
the extract medium, and cells were cultured for further 24 h
in the incubator.
2.5. Cell Morphology. The effect of ZnO-NP and TiO
2
-NP
suspensions on cell morphology in 2D and in 3D cell cul-
tures (hydrogel) was examined by phase contrast microcopy
(Olympus IX 50, Olympus Corporation, Tokio, Japan) after
the cells were exposed to nanoparticles for 24 h.
2.6. Cell Viability. After nanoparticle exposure the cell viabil-
ity was determined using either the CTB analysis (CellTiter-
Blue Cell Viability Assay, Promega, Madison, USA) or the
MTT assay (Sigma-Aldrich, Munich, Germany). The MTT
assay is based on the reduction of the yellow tetrazolium
dye MTT to the insoluble blue formazan by metabolic
active cells [21]. To perform the MTT assay the cell cul-
ture medium was removed from each well and 100𝜇L (2D
cell culture)/300𝜇L (3D scaffolds) of 10% MTT solution
(90 𝜇L DMEM) and 10 𝜇L MTT stock solution (5mg/mL
phosphate buffered saline) were added to each well and
incubated for 4 h at 37∘C/5% CO
2
. Afterwards 100 𝜇L (2D
cell culture)/200𝜇L (3D scaffolds) sodium dodecyl sulfate
(SDS Solution) (1 g SDS in 10mL 0.01M HCl) was added to
each well and samples were incubated for further 18 h. To
ensure that the formazan was released completely from the
scaffold, the samples were shaken at a speed of 700 rpm. The
absorption signal at 570 nm/630 nm was determined using a
microplate reader (Bio-Rad, Munich, Germany) to quantify
the results. Scaffolds without cells were used as background
controls.
Comparable to the MTT assay, the CTB assay is based
on the reduction of the blue dye resazurin to the purple
dye resorufin by metabolically active cells monitored via
fluorescence. For the 3D hydrogel cell cultures 100 𝜇L CTB
stock solution was added to achieve a final concentra-
tion of 10% CTB solution and the dye was incubated for
18 h at 37∘C/5% CO
2
. Samples with hydrogel and different
nanoparticle concentrations but without cells were used as
background control. The fluorescence signals at an extinc-
tion wavelength of 544 nm and an emission wavelength of
590 nm were determined using a microplate reader (Fluo-
roskan Acent,Thermo Fisher Scientific Inc., Waltham, USA).
For both assays the absorption/fluorescence signals of cell-
free controls with different nanoparticle concentration were
determined to prevent misinterpretations of the assays.
2.7. Electric Cell-Substrate Impedance Sensing. Electric Cell-
Substrate Impedance Sensing (ECIS) measurements were
performed tomonitor the cellular behavior online.Therefore,
cells were grown on 8W1E (8 well 1 electrode) ECIS slides
(Applied BioPhysics, USA). Each of the eight wells contains
an electrode covered with a gold film, used to apply an alter-
nating current (AC) signal. Cell attachment, cell spreading,
and cell morphological changes affect themeasured electrode
impedance which can be detected by ECIS Model 1600R
(Applied BioPhysics, USA). Initially, each slide was equili-
brated overnight with 400 𝜇L of standard culture medium.
Then, the mediumwas removed and 125,000 cells (A549 cells
or NIH-3T3 cells) in 400𝜇L standard culture medium were
seeded per well. One well remained cell-free as reference.
After approximately 48 h the cells had grown to confluence
and the impedance signal was stable. ZnO-NP or TiO
2
-NP
suspension in culture medium was added to the cells at least
in duplicate at a concentration of the calculated half maximal
inhibitory concentration (IC
50
) value. In addition, at least two
wells were filled with standard culture medium as control
while nanoparticles to the cell-free well were added at the
same concentration. The impedance signal was monitored
during the entire time of the measurement.
2.8. Quantification of the Expression Levels of il-8 and hsp70
mRNA. The expression of il-8 and hsp70 genes was analyzed
with quantitative real-time PCR (qPCR). In a T75 culture-
flask 25,000 cells/cm2 of A549 cells or NIH-3T3 cells were
incubated at 37∘C for 24 h before the cells were exposed to
ZnO-NP or TiO
2
-NP at a concentration of the IC
50
value
for 24 h. NIH-3T3 cells were exposed to 20𝜇g/mL ZnO-
NP/TiO
2
-NP and A549 cells to 40 𝜇g/mL. Afterwards, the
total RNA was isolated by using the RNeasy Plus Mini Kit
(QIAGEN, Hilden, Germany) following the manufacturer’s
instructions and the RNA concentration was measured
at 260 nm by Nanodrop ND-1000 (Peqlab Biotechnologie
GmbH, Germany). For cDNA synthesis 2 𝜇g of RNA and
3 𝜇L oligo (dt) primers (poly d(T) 12–18 Primer, Roth,
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Table 1: Sequences of the primers used in qPCR.
Gene name Gene bank accessionnumber (NCBI GenBank) Location (bp)
Expected size of PCR
amplicon (bp) Sequence (5
󸀠-3󸀠)
GAPDH NM 002046.3
880–900
126
F: AAGGTGGTGAAGCAGGCGTCG
1005–984 R: AATGCCAGCCCCAGCGTCAAAG
HPRT NM 000194.2
650–669
267
F: AAGCTTGCTGGTGAAAAGGA
897–916 R: AAGCAGATGCCCACACAACT
For A549 cells
IL-8 NM 000584.3
221–240
131
F: CAGTTTTGCCAAGGAGTGCT
351–332 R: AATTTCTGTGTTGGCGCAGT
Hsp70 (HSPA1A) NM 005345.5
2049–2068
138
F: GTGTAACCCCATCATCAGCG
2186–2166 R: CAATCTTGGAAAGGCCCCTAA
For NIH-3T3 cells
IL-8 NM 011339.2
338–357
110
F: GAATTTCCACCGGCAATGAA
447–428 R: TCCCGAATTGGAAAGGGAAA
Hsp70 (HSPA1A) NM 010478.2
2141–2161
104
F: CATCGAGGAGGTGGATTAGAG
2244–2225 R: ACCTTGACAGTAATCGGTGC
Germany) in a total volume of 27𝜇L (add with ddH
2
O)
were incubated at 65∘C for 5min and then held at 4∘C for
1min. Subsequently 8𝜇L M-MLV RT 5x Buffer (Promega,
USA), 4 𝜇L dNTPs (dNTP set, Thermo Scientific, USA),
and 1 𝜇L M-MLV Reverse Transcriptase (Promega, USA)
were added and the mixture was incubated at 37∘C for 1 h.
The qPCR was performed with a reaction volume of 25𝜇L,
containing 0.5 𝜇L (0.2 𝜇M) of each of the forward and reverse
primers (see Table 1), 25 ng cDNA template, and 12.5 𝜇L IQ
SYBR Green Supermix (Bio-Rad, USA). The measurements
were carried out on an iQ5 Multicolor Real-Time PCR
Detection System (Bio-Rad, USA) and all samples were run
in triplicate. In addition, the efficiency of each primer pair
was determined using serial dilutions of the cDNA template.
PCR reactions were performed at 95∘C for 3min followed
by 40 cycles of 95∘C for 10 sec and of 57∘C for 20 sec.
The data (comparative threshold (ct) values) were analyzed
using the Gene Expression Analysis for iCycler iQ Real-
time PCRDetection System (Bio-Rad, USA). Glyceraldehyde
3-phosphate dehydrogenase (GAPDH) and hypoxanthine-
guanine phosphoribosyltransferase (HPRT) were used as
endogenous control genes to normalize the expression of the
target genes. Therefore, the expression levels of hsp70 and of
il-8 are expressed as 𝑛-fold differences relative to the reference
genes.
2.9. Data and Statistical Analysis. For the determination of
the IC
50
values dose response curves were fitted to the data
obtained by theMTT or the CTB assay using OriginPro 8.5.0
SR1 (nonlinear curve fitting, growth/sigmoidal, DoseResp).
The data shown are from at least three independent exper-
iments triplicate (𝑛 ≥ 3). The ANOVA one-way analysis
(OriginPro 8.5.0 SR1) was performed for statistical analysis
and a significant effect was reported at ∗𝑝 < 0.05.
3. Results and Discussion
3.1. Development of a Cellular Screening System. In our
recent study we have constructed and validated a cell-based,
hierarchical screening system in order to realize the analysis
of a variety of nanoparticles and nanomaterials under defined
and reproducible conditions (Figure 1). For this purpose, the
scheme for biomaterials in tissue engineering published by
Bruns et al. (2007) served as a template for our screening
system for nanoparticles [22]. The idea of the screening
system is that toxicity measurements are done during the
course of nanomaterial development.The screening system is
divided into a prescreening, a fine-screening, and a complex-
screening (Figure 1). In the prescreening simple methods are
used for all materials, whereas more complicated techniques
are used for fine- and complex-screening which are applied
only to selected materials. Especially in fine screening, the
assays cover various impact areas on the cells.
After each screening step cells exhibiting a significant
variation as compared to nontreated cells are identified
(𝑝 < 0.05, ANOVA one way). Materials causing such sig-
nificant variations are classified as cytotoxic and thus not
further investigated and rejected, whereas the remaining
nanomaterials are subjected to further analyses. Continu-
ous communication (feedback) between the process chain
and the screening system is essential in order to opti-
mize nanoparticle development and associated safety testing.
Feedback should be given with regard to the toxicity and the
particle properties in order to select nanomaterials which are
profitable and which should be further analyzed. Thus, the
hierarchical structure facilitatesmaking decisions as to which
nanomaterials need complex, costly investigations or in vivo
studies thus avoiding unnecessary testing of the remain-
ing nanomaterials. Finally, only nanomaterials which pass
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Figure 1: Hierarchical cell-based screening system for nanoparticle safety testing. The screening system is divided in prescreening, fine-
screening, and complex-screening and allows examining of a variety of nanoparticles during nanoproduct development. Prescreening is
performed with all nanomaterials whereas complex cell systems are only applied to selected nanomaterials.
the whole screening system without significant side-effects
can reach the application level. Thus, our screening system
is highly efficient and cost minimizing and reduces animal
studies.
Before nanoparticles or nanomaterials can be analyzed
in the screening system, a thorough characterization is
needed. Therefore, a data-sheet is required which provides
information about the size, the surface modification, the zeta
potential, the aqueous stability, and the sterilizationmethods.
According to the data-sheet information and the desired
application of the nanomaterials, one specific type of
nanoparticle testing is applicable such as suspension, coating,
or extraction (detailed description is given below). For the
evaluation of the nanoparticle screening system, two differ-
ent, commonly used kinds of nanoparticles were selected:
ZnO-NP andTiO
2
-NP.While the focus in this study has been
on short-term nanoparticle exposure investigations, long-
term conditions can also be tested in this complex-screening
layout.
Concentrating on the desired application of the nanopar-
ticles and on their potential incorporation into the human
organism different cell lines were selected for the prescreen-
ing and for the fine-screening.Themain absorption routes are
via skin, via respiratory tract, and via gastrointestinal tract [1].
The skin, being the largest organ [1], provides a large target
surface for nanoparticles. Recent studies have reported the
penetration of nanoparticles [1] through the skin tissue which
means investigations of in vitro skin test systems are needed.
In addition, nanoparticles can be inhaled and can be absorbed
by pulmonary alveoli [1, 8]. Moreover, via the gastrointestinal
tract nanoparticles can reach the liver and accumulate there
in [1]. With regard to the described absorption routes, a
matrix of relevant cell lines is required to identify cytotoxic
effects of nanoparticles in vitro because various cell lines
display different sensitivities and cell responses [1, 23].
To avoid cell-type specific behavior it is important to
use different cell lines. Therefore, commonly used cell lines
such as A549 cells (lung model) and NIH-3T3 cells (skin
model) have been applied here. The use of mammalian
cell lines in the screening system has the advantage that
they provide reproducible results as cells are uniform, stan-
dardized, and well characterized. Thus, cell lines provide
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the first evidence concerning the toxicity of the nanomateri-
als.
However, using standardized cell lines bears the disad-
vantage that their cell behavior cannot be easily transferred
to in vivo conditions because they are often immortalized
or isolated from tumors [6]. In addition, the proliferation
rate of immortalized cell lines is often higher than that of in
vivo cells [6].Therefore, in the screening system primary cells
and complex cell systems are examined to better mimic real
tissue conditions in a human organism.These cell systems are
three-dimensional (3D) cell cultures where cells can develop
more in vivo-like cell-cell interactions and an extracellular
matrix [24, 25]. Secondly, dynamic conditions are performed
to mimic, for instance, the blood stream. Both cell systems
can finally be combined for a higher complexity and to
perform long-term exposure analysis. Since these models
require much more complex settings, they are used only with
selected nanomaterials in complex-screening.
3.2. Prescreening: Morphology Studies and Comparison of
Nanoparticle Suspensions, Coatings, and Extract Medium
3.2.1. Morphology Studies of A549 Cells and NIH-3T3 Cells
Exposed to ZnO-NP and TiO2-NP in 2D and 3D Cell Cultures.
For in vitro studies 2D cell cultures are needed in the
prescreening because they allow high-throughput screening.
Thus, different nanoparticles, nanoparticle concentrations,
and various cell types can be tested in parallel.The prescreen-
ing reduces the huge amount of nanomaterials obtained from
the process chain to a more manageable number. Decisions
have to be made concerning the question which nanoma-
terial requires further investigation in the fine-screening
or complex-screening. The impact of the cell viability after
nanoparticle exposure indicating cytotoxic effects is analyzed
with commonly used assays such as the MTT, the CTB,
or the WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-
5-tetrazolio]-1,3-benzene disulfonate) assay. With all three
assays, comparable results can be produced which only differ
in their sensitivity. Besides these viability measurements,
morphology studies are applied in the prescreening. Cell
morphology studies are important to support the results
obtained with cytotoxicity assays, especially with regard to
potential interference by the nanoparticles on the assay
compounds. Some harmful effects can be identified via cell
morphology changes, so in these cases false-positive results
may be detected.
To validate the significance of cell morphology studies for
screening cytotoxic effects of nanoparticles, A549 and NIH-
3T3 cells were treatedwith ZnO-NP or TiO
2
-NP, respectively.
In addition, the cells were grown in 2D as well as in 3D. For
3D cell cultures the cells were encapsulated in a hydrogel.
The cell morphology of nontreated and treated cells was
analyzed.The specific IC
50
value calculated from the viability
results for both cell lines and with both cell systems was
displayed. In Figure 2 the cell morphology of NIH-3T3 (c)
and A549 cells (g) grown in 2D and treated with ZnO-NP
is shown. In the standard culture media the NIH-3t3 cells
exhibit their characteristic contact arms to their neighboring
cells (Figures 2(a) and 2(b)). ZnO-NP treated NIH-3T3
cells at the IC
50
value changed their morphology turning
smaller and rounder, characteristic of dead cells. At higher
nanoparticle concentrations they became detached from the
surface. For A549 cells grown in 2D, the control cells had
a triangular shape and became round when ZnO-NP were
added (IC
50
value) (Figure 2(e)). In 3D the NIH-3T3 cells
displayed the same changes as observed in the 2D cell culture
(Figure 2(b)). In the hydrogel NIH-3T3 cells are highly
networked (Figure 2(b)). At the IC
50
value the cells turned
round (Figure 2(d)). On the contrary, A549 cells grown in
the hydrogel were round in the standard culture media as
well as in the ZnO-NP treated media (Figures 2(f) and 2(h)).
Thus, no significant differences in their morphology could
be revealed. For TiO
2
-NP no reduction in the viability was
determined and both cells lines did not show anymorphology
changes (data not shown).
In summary, the morphology studies should be regarded
as an important tool in the nanoparticle safety screening
system. In some cases, however, the viability assay is not
sufficient to prescreen the nanoparticles accurately. In this
context, for in vitro drug testing Quent et al. have reported an
overestimation of the viability of daunorubicin-treated cells
determined by the MTT assay [4]. The morphology study
clearly displays the release of detached cells indicating cell
death whereas the MTT was still reduced in the cells [4]. In
our study, ZnO-NP morphology changes of NIH-3T3 cells
could be observed in 2D as well as in the 3D hydrogels.
Also for A549 cells grown in 2D the toxic effect of ZnO-NP
was determined by the cell morphology studies. However, for
A549 cells growing in hydrogel this method failed to identify
toxic effects. Here, no changes in the morphology of the
A549 cells after adding ZnO-NP to the culture were observed
while the cell viability assay showed a significant reduction at
this concentration (Table 1). Furthermore, different 3D cell
culture models based on cell aggregation (spheroids), cell
encapsulation (hydrogel), and cell adhesion on scaffolds are
currently used to mimic a 3D environment. In particular,
the scaffold model hinders morphology studies as scaffolds
are not transparent. In conclusion, morphology studies can
support other cytotoxic assays while they can only detect
specific impacts of nanoparticle exposure.
3.2.2. Cell Viability Measurements of A549 Cells and NIH-
3T3 Cells Exposed to ZnO-NP and TiO2-NP in Suspension,
in Extract Medium, or on Coatings. For in vitro nanoparticle
safety testing, the methodological challenge is the prepara-
tion of stable, aqueous, physiological nanoparticle suspen-
sions because nanoparticles often agglomerate in biological
media. As reported by Jones and Grainger (2009) these
nanoparticle aggregations can affect several nanoparticle
properties such as size and cellular uptake [6]. Currently,
different dispersion protocols and various biocompatible sta-
bilizers are being examined for generating stable nanoparticle
suspensions [7, 26]. Protocols have thus been developed
for the dispersion of nanoparticles in FCS using various
centrifugation steps [7], in culture media [7] or in an
aqueous suspension [26]. Only with gum arabic as a stabilizer
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Figure 2: Morphology studies of NIH-3T3 cells (a–d) and A549 cells (e–h) grown on 2Dmonolayers (a, c, e, g) or encapsulated in a hydrogel
(3D cell culture) (b, d, f, h). NIH-3T3 cells were cultivated in standard culture medium (a, b) or were treated with 10𝜇g/mL ZnO-NP in 2D (c)
and in 3D (d). For A549 cells 40 𝜇g/mL ZnO-NP were added in 2D (g) and 300 𝜇g/mL ZnO-NP in 3D (h). The A549 control cells cultivated
in standard culture medium were displayed in (e) and (f). Morphology changes after ZnO-NP exposure were observed in 2D for both cell
lines whereas in 3D effects were only determined for NIH-3T3 cells.
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Figure 3: Viability of NIH-3T3 cells (a) and A549 cells (b) after ZnO-NP exposure determined with the MTT assay. The cells were treated
with nanoparticle suspension, coating, or extract medium. The signals of untreated cells were set as 100%. Data points are means ± SD for
𝑛 ≥ 3. ∗𝑝 < 0.05.
the ZnO-NP suspension was found to be stable for more
than five days [26]. In this study alternative in vitro tech-
niques were developed and validated to avoid the described
problemswith nanoparticle suspensions.We studiedwhether
similar cell viability results can be obtained with nanoparticle
suspensions, extract medium, and coatings. For this purpose
both cell lines were seeded on nanoparticle coatings and via-
bility measurements were carried out. Additionally, extract
media from TiO
2
-NP and ZnO-NP coatings, respectively,
were prepared according to the ISO 10993-12:2012 standard
for medical devices and subsequently used for the treatment
of the cells [20]. Thereby, we wanted to monitor whether
nanoparticles are dissolved from the coatings thus influenc-
ing the viability of the cells.
For TiO
2
-NP no significant reduction in the viability of
either cell line tested was observed for all three methods (see
supporting information, Figure 8; see Supplementary Mate-
rial available online at http://dx.doi.org/10.1155/2015/691069).
On the other hand, the viability of the cells was reduced
by ZnO-NP in a dose-dependent manner. In Figure 3
the viability of ZnO-NP suspensions, coatings, and extract
medium upon exposure to NIH-3T3 and to A549 cells is
displayed. In addition, in Table 2 the IC
50
value of the viability
measurements are summarized.
For ZnO-NP toxic effects were detected with all three
methods and with both cell lines performing the MTT
assay. NIH-3T3 cells were found to be more sensitive to
ZnO-NP than A549 cells; thus different cell lines apparently
show different sensitivity to nanoparticles. The NIH-3T3
cells exhibited the same IC
50
value for ZnO-NP suspensions,
coatings, and extract medium. On the contrary, the IC
50
value determined for ZnO-NP suspensions in A549 cells
was found to be half of the IC
50
value determined with
Table 2: Calculated IC50 value of NIH-3T3 cells and A549 cells
treated with ZnO-NP suspensions, coatings, or extract medium
(MTT assay). For A549 cells the IC50 value for nanoparticle
suspensions is twice lower as compared with the respective coatings.
Data points are mean ± SD for 𝑛 ≥ 3.
IC50 value [𝜇g/cm
2
]
NIH-3T3 cells A549 cells
Suspension 3 ± 1 18 ± 5
Coating 2 ± 1 31 ± 8
Extract medium 2 ± 2 30 ± 8
the coating experiments. Therefore, instead of suspension
testing for the identification of toxic nanoparticles, coating
analysis can be a good alternative, especially for nanoparticles
which agglomerate in standard culturemedia. For the coating
and extract medium results no differences in the IC
50
values
were observed for either cell line. Thus, the determined
reduction in the cell viability is apparently caused by the
release of ZnO-NP from the coating. Our results clearly
demonstrate that ZnO-NP exposure induces a decrease of the
cell viability indicating toxic effects.
Obviously, nanoparticle effects to human cell lines can
be investigated either with stable suspensions, with coatings,
or with extract medium. The choice of strategy depends
on the nanoparticle properties as well as on the desired
application of the nanoproduct.While for somenanoparticles
a stable aqueous suspension in the cell culture medium can
be produced, other nanoparticles agglomerate under these
conditions. When evaluating the potential risk of nanopar-
ticles to human beings, it should be considered that nanopar-
ticles often may not reach the human organism as individ-
ual nanoparticles but rather as nanoparticle agglomerates.
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In in vitro studies, proteins present in the media often adsorb
to the nanoparticles [2] thus affecting the cell response of the
nanoparticle treatment.The same effect may take place in the
human organism. Consequently, nanoparticle agglomerate
analysis can make sense, for example, to predict the in vivo
cell behavior. On the contrary, for the in vitro investigation of
nanoparticle effects in the respiratory tract, stable nanoparti-
cle suspensions are required. Inhaled particles with diameters
below 2.5 𝜇m can reach the pulmonary alveoli where they
can be absorbed [8]. For any nanoparticle test system it is
therefore important to consider the relevance for human
health effects [27].
As an alternative technique for nanoparticle in vitro test-
ingwe performed the so-called coatingmethod.However, the
proliferation rate of adherent cells can be affected by nanos-
tructured surfaces. Several studies have demonstrated that
the surface roughness of the cell culture plates influences the
cellular behavior [28–30]. Therefore, the stability of certain
nanoparticle coatings (nanomaterials and nanocomposites)
and the effect of potentially solved nanoparticles to the
humanorganismmay bemore relevant.Thus, the preparation
of extract media is the chosen strategy for certain nanomate-
rial applications such as for medical devices, window glasses,
or sanitation. Comparable with our extract experiments,
Paddle-Ledinek et al. (2006) have used this method before
to test wound dressings coated with nanoparticles [31]. In the
present study, it could be shown that nonstable nanoparticle
coatings require particular care during the testing process.
Hence, measurements of the toxic effect of ZnO-NP with
suspensions, with coatings, and with the extraction method
demonstrated that extract testing is an alternative indirect
method to investigate the cytotoxicity of nanomaterials.
In summary, the nanoparticle screening system intro-
duced here is capable of analyzing suspensions, coatings, as
well as coating extractions regarding the respective appli-
cation of the nanomaterials. Moreover, the analysis of the
extract also monitors the stability of the coating.
3.3. Fine-Screening: Gene Expression Analysis and ECIS Mea-
surements of A549 Cells and NIH-3T3 Cells Exposed to ZnO-
NP and TiO2-NP. Following the prescreening assays, fine-
screening tests were performed to provide higher sensitiv-
ity and to yield detailed information concerning the cell
responses induced by the nanoparticle exposure. To avoid
potentialmisinterpretations resulting from, for example, pos-
sible interference of nanoparticleswith the assay components,
different methods based on fluorescence or luminescence are
used here in the fine-screening. Additionally, several positive
and negative controls are needed. Moreover, for an accurate
in vitro nanoparticle fine-screening, various biological effects
of the nanoparticles were analyzed. The energy metabolism
in the cells can, for example, be investigated with adenosine
triphosphate (ATP). For cell death analysis, the release of
lactate dehydrogenase (LDH) indicates necrosis and the
caspase activity or the annexin V-FITC/PI assay indicating
apoptosis can be performed. Changes in the proliferation
rate of the cells can be detected with the bromodeoxyuridine
(BrdU) assay which is based on the integration of BrdU, a
chemical analogue of the nucleoside thymidine. BrdU can be
detected by labeled antibodies and indicates the proliferation
rate of the cell. Moreover, DNA damage in cells caused by
the exposure to nanoparticles can be observed by the alkaline
microelectrophoresis (comet assay). Also, the generation of
reactive oxygen species (ROS) induced by nanoparticles can
be determined, thus demonstrating stress for the cells. A
commonly used assay for the ROS detection is the DCF assay.
In addition, nanoparticlesmay also affect the gene regulation,
so the expression of selected marker genes can be quanti-
fied using real-time PCR or microarray analysis. Molecular
markers can, for instance, be mitosis markers, heat-shock
proteins, interleukins, or apoptosis markers. While all the
described methods are endpoint assays, the Electric Cell-
Substrate Impedance Sensing (ECIS) measurement provides
online data. Cell morphology changes such as cell rounding
or surface detachment can be detected immediately after
the addition of nanoparticles [2]. Moreover, no additional
compounds are required for this alternative technique, mini-
mizing false-positive results [32].
In our study, we investigated the effects of ZnO-NP and
TiO
2
-NP on gene expression using real-time PCR analy-
sis. We selected two established biomarkers: il-8 indicating
inflammation [33, 34] and hsp70 indicating oxidative stress
responses [35, 36]. In NIH-3t3 cells (Figure 4(a)) as well as in
A549 cells (Figure 4(b)), the il-8 mRNA level was increased
when cells were exposed to ZnO-NP. Furthermore, ZnO-
NP induced hsp70 expression in A549 cells (Figure 4(b)).
On the contrary, exposing NIH-3T3 cells and A549 cells to
TiO
2
-NP did not lead to higher levels of the investigated
biomarkers. The real-time PCR results clearly demonstrated
that ZnO-NP induce inflammation in both investigated cell
lines and additionally oxidative stress in A549 cells. Several
studies confirmed our investigation. In human bronchial
epithelial cells, for example, ZnO-NP exposure increased the
expression of il-8mRNA [33] as well as the protein level [33,
37]. Also, il-8mRNA secretion has been used for identifying
cytotoxic effects of other nanoparticles, such as carbon
nanotubes and polystyrene nanoparticles [38]. Exposure of
TiO
2
-NP to keratinocytes [7], human monocytes, and lung
epithelial cells [36] did not cause inflammation. Furthermore,
for TiO
2
-NP an increase of the il-8 gene expression in A549
cells was only achieved at unrealistically high concentration
(400 𝜇g/cm2) with regard to in vivo conditions [34].However,
in vivo studies with mice demonstrated that TiO
2
-NP induce
increased levels of several interleukins such as il-8 mRNA
[39, 40].
The second chosen biomarker, hsp70, was already vali-
dated for investigation of the effect of several nanoparticles.
Hsp70’s virtues include that it is a very sensitive biomarker for
cellular stress responses, it is well characterized [41, 42], and it
precludes false protein-folding [43]. The toxic effect of silver
nanoparticles was determined in vivo by an increased level of
hsp70 mRNA [44, 45] and of Hsp70 protein [41] indicating
oxidative stress. Furthermore, Cu-NP [42], carbon-black
nanoparticles [46], andCdSe/ZnSnanoparticles [47] induced
hsp70 expression.While in our study ZnO-NP exposure leads
to a higher hsp70 expression in A549 cells, this effect was not
observed for NIH-3T3 cells. According to Chen et al. (2012),
NIH-3T3 cells exhibited a lower heat-shock response than
10 Journal of Nanomaterials
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Figure 4: Relative mRNA expression of il-8 and hsp70 from NIH-3T3 cells (a) and A549 cells (b) upon treatment with ZnO-NP or TiO
2
-NP
for 24 h. NIH-3T3 cells were exposed to 20𝜇g/mL and A549 cells to 40 𝜇g/mL ZnO-NP or TiO
2
-NP. Data points are means ± SD for 𝑛 ≥ 4.
Significant differences versus the control group are indicated in the figure (ANOVA, one way). ∗𝑝 < 0.05.
other cell lines; thus the sensitivity to nanoparticle response
detection was reduced [43]. In addition, different cell lines
revealed a variance in their exposure time-course response
[43]. For TiO
2
-NP no significant changes of hsp70 expression
relative to the control cells were observed for Thp-1 cells
(human monocytes) or for NCI-H292 cells (human lung
epithelial cells) [36] but not for other cell lines such as NIH-
3T3 cells or HepG2 cells [43]. On the contrary, the hsp70
expression in mice (in vivo) was downregulated after TiO
2
-
NP exposure [39, 40]. Presumably, hsp70 reduction could
indicate a detoxification process of the cells [40].
ECIS measurements were used for the online monitoring
of nanoparticle effects in the cells. Instead of endpoint
measurements, cellular response to nanoparticle addition
can be observed directly by this method and no additional
dye is needed. Thus, interference of assay compounds with
nanoparticles can beminimized.The results of the impedance
measurements of NIH-3T3 cells (Figure 5(a)) and of A549
cells (Figure 5(c)) cultivated with ZnO-NP were compared
with the control cells.
After addition of ZnO-NP to the cells, the impedance
signal dropped immediately for the NIH-3T3 cells. Interest-
ingly, for A549 cells the impedance signal increased after
ZnO-NP addition during the first 10 h before it decreased
again. The cells treated with ZnO-NP lost their cell-cell
interaction, became smaller, and detached from the surface.
The decrease of the impedance signal indicates the cell death;
thus ZnO-NP exhibited a toxic effect to the cells. The slight
increase of the impedance signal for A549 cells after ZnO-NP
addition had been already reported by Seiffert et al. (2012)
[32]. Such an effect cannot be explained with proliferation as
A549 cells have doubling times of 24 h; thus another cellular
response must have occurred [32]. For TiO
2
-NP no changes
in the impedance signal were revealed with both cell lines
(Figures 5(b) and 5(d)) indicating no cellular changes. Also,
the impedance of a cell-free control did not change.Thus, the
nanoparticles themselves did not affect the impedance signal.
ECIS measurements have previously been used for cyto-
toxicity analysis of nanoparticles. A significant decrease in
the impedance signal indicating cytotoxicity was determined
for ZnO-NP as well as for CuO-NP but not for TiO
2
-NP
[32]. Furthermore, the calculated IC
50
value determined with
the viability assay was found to be comparable with the one
determined by the cell-impedance measurements after 24 h
[32]. For anatase TiO
2
-NP no significant cytotoxic effect was
observed [48, 49] and for rutile TiO
2
-NP it was observed only
at high concentrations (IC
50
value > 200𝜇g/mL) [48, 50].
Therefore, the effect of TiO
2
-NP on the cellular behavior
appears to be dependent on the particle size as well as on the
shape.
In our study during the fine-screening stage, TiO
2
-NP
were not found to cause a significant variation either in the
gene expression analysis or in the ECIS measurements. Thus,
these particles should be further analyzed in the complex-
screening mode.
3.4. Complex-Screening: Comparison of Cell Viability of A549
Cells and of NIH-3T3 Cells Exposed to ZnO-NP and TiO2-NP
in 2D and in Different 3D Cell Culture Models. The complex-
screening is performed for the remaining nanomaterials not
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Figure 5: Electric Cell-Substrate Impedance Sensing of NIH-3T3 cells (a, b) and A549 cells (c, d) to monitor nanoparticle toxicity. The cells
were grown to confluence before nanoparticle exposure. Dynamic changes in the impedance signal of NIH-3T3 cells to 0 and 20𝜇g/mL
suspensions of ZnO-NP (a) or TiO
2
-NP (b) are displayed. For A549 cells the effect of 40𝜇g/mL of ZnO-NP (c) and TiO
2
-NP (d) was
investigated. Cell-free medium with nanoparticles was used as reference. The measurements were performed with a 16 kHz ac source. The
time point for nanoparticle addition is indicated with the black arrow. Data points are means ± SD for 𝑛 ≥ 3.
exhibiting any clear toxic effects during the fine-screening
to apply more extensive in vitro methods. As currently used
2D cell culture models have several limitations [25, 51], 3D
cell culture systems are employed here. The cells were grown
in a more physiological cell environment to better predict
the cellular behavior in the organism. The 3D cell culture
exhibits a higher complexity compared to the conventional
2D cell culture and is more expensive. Currently, different
models have been developed to enable in vitro 3D cell growth
such as cell spheroids, cell encapsulation in hydrogel [52],
or cell adhesion on scaffolds. Secondly, the bloodstream
can be mimicked by cells growing under continuous flow
conditions (2D cell culture). Here, a shear stress is applied to
the cells during nanoparticle exposure. Therefore, to realize
both aspects in the complex-screening, it is divided into three
sections (Figure 1). In the first section the methods used in
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the prescreening are performed either on a 3D cell culture
model or under continuous flow conditions. Afterwards in
Section 2, the methods of the fine-screening are performed.
Finally, after the nanoparticles have been tested separately in
the cell culture systems a combination of 3D cell culture and
continuous flow conditions should be performed (Section 3).
In contrast to the previously described methods, long-term
exposure analysis can also be carried out hereby. These
experiments provide more relevant results, so in vivo studies
should follow when no significant variation is detected.Thus,
the complex-screening can bridge the gap between the cell-
based in vitro testing and the in vivo studies, thereby reducing
the amount of required animal studies.
In our studywe compared different 3D cell culturemodels
and their applicability for the investigation of nanoparticle
toxicity. NIH-3T3 cells and A549 cells were seeded on colla-
gen scaffolds or were encapsulated in a hydrogel.The scaffold
model as well as the encapsulation of cells in the hydrogel
was developed within the present study. For both of these 3D
cell culture models we have optimized parts of the procedure
like the cell density and incubation for cell growth and the
assay performance. The composition of the semisynthetic
PEG-fibrinogen-based hydrogel mix was tuned to create a
defined structure and to enable cell growth. The cells were
treated with different concentrations of ZnO-NP or TiO
2
-NP
and the viability of the cells was determined. In addition, the
two 3D cell culture models were compared with the already-
published data for cell spheroids [19]. As described above,
not all assays can be combined with all cell culture systems.
The viability assays differ in the solubility of the detection-
dye. Whereas the MTT assay generates an insoluble product,
the reagent used in the CTB assay is soluble. In our study we
preferred the CTB assay to measure the viability of the cells
grown in the hydrogel because no additional solution stepwas
needed for detection. On the other hand, for the cells grown
on the collagen scaffold, diffusion limitations of the reactive
dye may affect the results. To avoid only cells on the outer
scaffold surfacemetabolizing the dye, we used theMTT assay
instead. Here, the formed blue formazan was trapped in the
cells once MTT was metabolized. Thus, the MTT was able
to reach the cells inside the scaffolds as well and the viability
of all living cells can be revealed. For a better comparison
of the 3D cell culture results, both assays were performed
with the 2D cell culture as well. Figure 6 displays the viability
of both cell lines after ZnO-NP exposure determined with
the CTB assay or the MTT assay. The cells were encapsu-
lated in hydrogel, seeded on scaffolds, or cultured on 2D
monolayers.
In Table 3 the calculated IC
50
values for ZnO-NP in the
2D cell culture as well as in the 3D cell culture models are
summarized for A549 and for NIH-3T3 cells. Additionally,
the spheroid results from our previous study are listed to
allow a comparison of all three 3D cell culture models [19].
Again ZnO-NP reduced the viability of the cells in a dose-
dependent manner in the 2D as well as in the 3D cell
cultures. The results of the two different cell viability assays
did not show a significant difference for the 2D cell culture.
The choice of the viability assay for cells growing in 3D
is dependent on the used 3D model. For the 3D scaffold
Table 3: Comparison of calculated IC50 values for ZnO-NP of
2D cell culture and different 3D cell culture models. NIH-3T3 cells
and A549 cells were attached on collagen scaffolds, encapsulated in
hydrogel or aggregated in spheroids to grow in 3D. After exposure
to ZnO-NP the viability of the cells was determined using either the
MTT assay or the CTB assay. Values are means ± SD for 𝑛 ≥ 3. ∗Data
were already published by Sambale et al. 2015 [19].
Viability assay IC50 value [𝜇g/mL]
NIH-3T3 cells A549 cells
2D MTT 10 ± 3 58 ± 16
2D∗ CTB 15 ± 6 54 ± 12
3D scaffold MTT 11 ± 2 75 ± 18
3D hydrogel CTB 7 ± 3 328 ± 13
3D spheroids∗ CTB 9 ± 1 42 ± 13
model the MTT assay and for 3D hydrogel the CTB assay
gave reliable results. According to the IC
50
value, the NIH-
3T3 cells were more sensitive to the ZnO-NP than the A549
cells. For NIH-3T3 cells only minor differences in the IC
50
values were observed, but for A549 cells in the hydrogel
a more than fivefold higher IC
50
value was determined.
Also, the value for the scaffold model was found to be
higher. However, the spheroid model displayed a slightly
lower IC
50
value in comparison to the 2D monolayer culture
[19].
For TiO
2
-NP no significant reductionwas observed in 2D
as well as in 3D (hydrogel and scaffold model) with either
cell line (Figure 7). Interestingly, in our previous study we
observed that TiO
2
-NP induced the formation of several
smaller spheroids [19].
Differences of 2D and 3D cell cultures for toxicity testing
have already been reported in the literature. Controversial
results showed increased, decreased, or equal cell sensitivity
in 3D cultures when compared to 2D monolayers [24,
53]. Lee and colleagues showed a reduced toxic effect in
HepG2 spheroids for cadmium telluride (CdTe) and for gold
nanoparticles in comparison to the 2D cell culture [54].
Drug screening analysis of aflatoxin B1, amiodarone, valproic
acid, and chlorpromazine with HepaRG spheroids [24] and
of staurosporine and chlorambucil with HCT116 spheroids
[53] demonstrated differences in their half maximal effective
concentration (EC
50
) value for 2D and 3D cell cultures. In
our study we discerned A549 cells in the hydrogel to be
less sensitive to ZnO-NP than the cells in 2D. In recent
studies it was shown that gold nanoparticles can bind to
hyaluronic acid hydrogel, thus limiting the cell-nanoparticle
interaction [55]. However, for NIH-3T3 cells no significant
difference in the sensitivity of 2D cells or 3D hydrogel model
cells was observed. Thus, limitations of nanoparticle pene-
tration through the hydrogel can be excluded. In addition,
Xu et al. also demonstrated that cells grown in hyaluronic
acid hydrogel were less sensitive to doxorubicin-loaded
polymer nanoparticles than cells grown on 2D monolayers
[56].
In summary, the three 3D cell culture models pro-
vide different critical concentrations in vitro for ZnO-NP.
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Figure 6: Viability of NIH-3T3 cells (a, b) and A549 cells (c, d) after ZnO-NP exposure determined with the CTB assay (a, c) or the MTT
assay (b, d). The cells were encapsulated in hydrogel (a, c), seeded on scaffolds (b, d), or cultured on 2D monolayers. The signals of untreated
cells were set as 100%. Data points are means ± SD for 𝑛 ≥ 3. ∗𝑝 < 0.05.
Therefore, for a solid prediction for the subsequent in vivo
studies the suitability of the 3D model and the later appli-
cation of the tested nanomaterial has to be in the focus.
With spheroids limitations of nutrients, oxygen and other
metabolites present in tumor tissues can be investigated
[51]. Thus, spheroids are interesting for tumor modeling.
This 3D model can be used for nanoparticle development
for tumor therapies and nanomedicine. In contrast, the
hydrogel and the scaffold 3D model are more representative
to mimic real tissue conditions in the human organism.
Formation of model tissues and organs could be realized
[51]. These models can find applications to clarify nanopar-
ticle risks and to support industrial nanoparticle develop-
ment.
4. Conclusions
We have developed a hierarchical cell-based screening sys-
tem for nanomaterial toxicity testing, which is divided in
a pre-, a fine-, and a complex-screening. Therefore, a set of
high-throughput cytotoxicity assays as well as complex cell
culture models such as 3D cell culture or dynamic cultivation
were integrated. In future work, the screening system could
also be extended to long-term studies using a bioreactor.
Initially, in the current study we focused on ZnO-NP and
TiO
2
-NP because of their frequent use in many applications.
In our future studies we will extend our investigations
to a large set of different nanoparticles. Therefore, other
nanoparticles will be screened as well. Regarding the later
14 Journal of Nanomaterials
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Figure 7: Viability of NIH-3T3 cells (a, b) and A549 cells (c, d) after TiO
2
-NP exposure determined with the CTB assay (a, c) or the MTT
assay (b, d). The cells were encapsulated in hydrogel (a, c), seeded on scaffolds (b, d), or cultured on 2D monolayers. The signals of untreated
cells were set as 100%. Data points are means ± SD for 𝑛 ≥ 3.
application, the effects of the nanoparticles can be examined
in suspension, coatings, or extract media. A high amount of
nanomaterials can be analyzed extensively, so that only for
selected nanoparticles the application of in vivo studies will
be needed. Indeed, in vivo studies cannot be replaced entirely
but can be significantly reduced applying our screening
system. As case studies, the effects of zinc oxide (ZnO-
NP) and titanium dioxide nanoparticles (TiO
2
-NP) were
screened. ZnO-NP revealed cytotoxic effects to mammalian
cells in 2D cell culture as well as in 3D cell culture, thus
reducing cell viability and inducing inflammation and oxida-
tive stress. On the contrary, for TiO
2
-NP no significant
variation was observed with the used methods. We clearly
demonstrated that assays have limitations and that the choice
of the cell line may affect the results. In comparison to NIH-
3T3 cells, A549 cells were less sensitive to the investigated
nanoparticles and did not adhere to the 3D hydrogels.
While microscopic detection of morphology changes was
possible in 2D cell cultures, this method was critical in 3D
cell cultures to identify toxic nanoparticles. Electric Cell-
Substrate Impedance Sensing (ECIS) measurements provide
an excellent method for the noninvasive online monitoring
of cellular responses to nanoparticles and were hence placed
in the fine-screening part of the overall assay. Interference of
dyes with the nanoparticles can be excluded employing this
method.
In conclusion, the developed screening system can bridge
the gap between a constantly increasing nanotechnology and
Journal of Nanomaterials 15
comprehensive risk assessment to define safety provisions for
workers and customers.
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